Search Clinical Trials
585,525 trials
ID
Status
Phase
Title
Sponsor
NCT07598864
"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"Chittagong Medical CollegeNot Yet RecruitingPhase 3
NCT07598864Not Yet Recruiting
Phase 3
"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Di...Chittagong Medical Colleg...
NCT07598955
Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic CarcinomaBeijing BiotechRecruitingPhase 1
NCT07598955Recruiting
Phase 1
Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory...Beijing Biotech
NCT07600073
Tolerability of Remimazolam Versus Midazolam in EUSAzienda Socio Sanitaria Territoriale di LeccoRecruiting
NCT07600073Recruiting
—
Tolerability of Remimazolam Versus Midazolam in EUSAzienda Socio Sanitaria T...
NCT07600372
Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive CpsulitisGreen International UniversityCompletedNot Applicable
NCT07600372Completed
Not Applicable
Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive CpsulitisGreen International Unive...
NCT07598045
Efficacy of Anti-IL-6 Treatments on Migraine in Patients Treated With Anti-IL-6 for a Rheumatological ConditionUniversity Hospital, Clermont-FerrandNot Yet Recruiting
NCT07598045Not Yet Recruiting
—
Efficacy of Anti-IL-6 Treatments on Migraine in Patients Treated With Anti-IL-6...University Hospital, Cler...
NCT07598435
Rhythmic Initiation vs Isometric Training for Arm Recovery After StrokeUniversity of FaisalabadRecruitingNot Applicable
NCT07598435Recruiting
Not Applicable
Rhythmic Initiation vs Isometric Training for Arm Recovery After StrokeUniversity of Faisalabad
NCT07600619
Salivary α-Amylase as a Non-Invasive Biomarker of PRF-Enhanced Wound Healing After Third Molar SurgeryHasanuddin UniversityCompletedNot Applicable
NCT07600619Completed
Not Applicable
Salivary α-Amylase as a Non-Invasive Biomarker of PRF-Enhanced Wound Healing Aft...Hasanuddin University
NCT07599852
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D PatientsUniversity of Alabama at BirminghamNot Yet RecruitingNot Applicable
NCT07599852Not Yet Recruiting
Not Applicable
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D PatientsUniversity of Alabama at...
NCT07599748
Parasternal and Adductor Canal Blocks in CABGZonguldak Bulent Ecevit UniversityNot Yet RecruitingNot Applicable
NCT07599748Not Yet Recruiting
Not Applicable
Parasternal and Adductor Canal Blocks in CABGZonguldak Bulent Ecevit U...
NCT07599280
Universal STAR-T Cell Injection in R/R Autoimmune Diseases.China Immunotech (Beijing) Biotechnology Co., Ltd.Not Yet RecruitingPhase 1
NCT07599280Not Yet Recruiting
Phase 1
Universal STAR-T Cell Injection in R/R Autoimmune Diseases.China Immunotech (Beijing...
NCT07597954
Reciprocal Mother-Infant Voice Exposure in the Neonatal Intensive Care UnitBiruni UniversityCompletedNot Applicable
NCT07597954Completed
Not Applicable
Reciprocal Mother-Infant Voice Exposure in the Neonatal Intensive Care UnitBiruni University
NCT07600255
Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's DiseaseSecond Affiliated Hospital of Wenzhou Medical UniversityCompleted
NCT07600255Completed
—
Assessment on the Deep Remission Rate and Its Influencing Factors of Individuali...Second Affiliated Hospita...
NCT07599397
Evaluation of the Changes in Matrix Metalloproteinase-9 Levels With Salvadora Persica (Miswak) in Periodontal Fibroblasts and Gingival Crevicular Fluid in Patients With PeriodontitisCairo UniversityNot Yet RecruitingEarly Phase 1
NCT07599397Not Yet Recruiting
Early Phase 1
Evaluation of the Changes in Matrix Metalloproteinase-9 Levels With Salvadora Pe...Cairo University
NCT07598383
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisJiangsu vcare pharmaceutical technology co., LTDNot Yet RecruitingPhase 2
NCT07598383Not Yet Recruiting
Phase 2
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical St...Jiangsu vcare pharmaceuti...
NCT07598396
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisHoffmann-La RocheRecruitingPhase 2
NCT07598396Recruiting
Phase 2
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythemato...Hoffmann-La Roche
NCT07600320
Fareon Open Label Device Clinical TrialIcahn School of Medicine at Mount SinaiNot Yet RecruitingNot Applicable
NCT07600320Not Yet Recruiting
Not Applicable
Fareon Open Label Device Clinical TrialIcahn School of Medicine...
NCT07600307
Evaluating a Digital Toolkit for IPVMedical University of South CarolinaNot Yet RecruitingNot Applicable
NCT07600307Not Yet Recruiting
Not Applicable
Evaluating a Digital Toolkit for IPVMedical University of Sou...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed4 (20%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 22 (10%)
Phase 31 (5%)
Early Phase 11 (5%)